Let The Pharmaceutical Companies Know How You Feel! 

The following companies plan to use the new aborted fetal cell line PER C6 to develop important new vaccines.  They believe the public accepts such practices since there are existing vaccines using aborted fetal cell lines MRC-5 and WI-38 and the market is flourishing.  Children of God for Life knows that if the majority of people in America knew what these companies were up to, it would swiftly bring an end to their sordid business.  Stated Debi Vinnedge, Executive Director in a recent letter to these companies:

"We know it is unnecessary to use this cell line and in doing so, your company image portrays a lack of concern for the sanctity and dignity of human life.  It is really no different than the action of Nazis who performed experiments on the murdered Jews during the holocaust.  A helpless segment of society was targeted and used as a commodity for the benefit of others then, just as the remains of these babies are being used today.  And while we understand and support the need for new and effective treatments for infectious disease, such products should only be developed using the highest ethical standards."

Merck & Company
Uses WI-38 and MRC-5 in their MMR, Chickenpox, 
Hepatitis-A vaccines; Plans on using PER C6 
in a new HIV vaccine.

Merck & Company

Richard Clark, CEO
One Merck Drive
P.O. Box 100

Whitehouse Station, NJ 08889-0100

Aventis Pasteur
Uses MRC-5 in their Rabies Vaccine ; plans to use PER C6 in future products

David J. Williams, President & CEO
Aventis Pasteur
Box 187 Discovery Drive
Swiftwater, PA  18370

 

Chiron Corporation

Plans to use PER C6 in a new flu vaccine. Tell them not to!

 

Chiron Corporation
Attention: John Lambert, President Chiron Vaccines

4560 Horton Street

Emeryville, CA   94608-2916

 

Pfizer Corporation
Withdrew from PER C6 license agreement 
Write to thank them!
Hank McKinnell, CEO
Pfizer Corp. World Headquarters
235 E 42nd St.
New York, NY  10017

Novartis
Plans on using PER C6 in future. Write to tell them not to!

Thomas Ebeling, CEO
Novartis Pharmaceuticals Corp.
One Health Plaza
East Hanover, NJ  07936-1080

Glaxo SmithKline 
(formerly SmithKline Beecham)
Uses MRC-5 in their Hepatitis-A and Twinrix 
(Hepatitis-A-B combo) vaccines; plans on using 
PER C6 in future
Dr Jean-Pierre Garnier
Glaxo SmithKline

1 Franklin Plaza P.O. Box 7929

Philadelphia, PA  19101

Schering-Plough
Plans on using PER C6 in future. Write to tell them not to!
Richard Jay Kogan, CEO
Schering-Plough
2000 Galloping Hill Rd.
Kenilworth, NJ  07033-0530

MedImmune, Inc.
Plans on using PER C6 in a new Flu Vaccine
David M. Mott, Chief Executive Officer
MedImmune, Inc.
35 W. Watkins Mill Rd.
Gaithersburg, MD 20878

National Institutes of Health 
(Governed by the Dept. of HHS)
Plans on using PER C6 in new Ebola Vaccine.
The Honorable Michael O. Leavitt                    
Department of Health & Human Services              
200 Independence Avenue, S.W. Room 615-F                   
Washington, D.C. 20201  

CDC

Dr. Julie Gerberding
Centers for Disease Control
1600 Clifton RD NE MS D66
Atlanta, GA  30333

FDA
Center for Biological Evaluation & Review
Federal Food and Drug Administration
5600 Fishers Lane
Rockville, MD  20895 

                                                                

 

 We have the right to protect the health and safety of our families without violating our moral or religious beliefs!

Get involved!  Click here to learn more!              Letter Writing Tips - Samples